semaglutide and menopause Embracing Change: The Benefits of for Women in Hormone therapy may boost weight
Description
Switching to tirzepatide (a dual GLP-1/GIP agonist) activates an additional metabolic pathway and often produces faster results in semaglutide-plateau patients
GLP-1 receptor agonists (GLP-1RAs) are currently used for treating type-2 diabetes and obesity because of their effects on appetite, food intake, and body weight loss
Prescribing restrictions are likely to relax over time, and coverage and penetration improve, as increased competition and the entry of generics drive price erosion
Care may be delivered asynchronously where permitted by state law, with follow-ups about every 24 weeks
